[1] Fox RI, Stern M, Michelson P.Update in Sjogren syndrome[J]. Curr Opin Rheumatol, 2000, 12(5):391-398.
[2] Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjogren's syndrome[J]. Autoimmun Rev, 2010, 9(5):A305-A310.
[3] Li CL, He J, Li ZG, et al. Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: an animal study[J]. J Craniomaxillofac Surg, 2013, 41(7):610-615.
[4] Dafni UG, Tzioufas AG, Staikos P, et al. Prevalence of Sjogren's syndrome in a closed rural community[J]. Ann Rheum Dis, 1997, 56(9):521-525.
[5] Bowman SJ, Ibrahim GH, Holmes G, et al. Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK[J]. Scand J Rheumatol, 2004, 33(1):39-43.
[6] Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China[J]. Rheumatol Int, 2009, 29(5):481-490.
[7] Bournia VK, Vlachoyiannopoulos PG. Subgroups of Sjogren syndrome patients according to serological profiles [J]. J Autoimmun, 2012, 39(1-2):15-26.
[8] Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group [J]. Ann Rheum Dis, 2002, 61(6):554-558.
[9] Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome[J]. Arch Intern Med,2004,164(12):1275-1284.
[10] Yilmaz YF, Titiz A, Yurur-Kutlay N, et al. Congenital bilateral parotid gland agenesis in Klinefelter syndrome [J]. J Craniomaxillofac Surg, 2010, 38(4):248-250.
[11] Longman LP, Higham SM, Bucknall R, et al. Signs and symptoms in patients with salivary gland hypofunction [J]. Postgrad Med J, 1997,73(856):93-97.
[12] Zheng LY, Kim E, Yu CQ, et al. A retrospective case series illustrating a possible association between a widened hilum and sialolith formation in the submandibular gland[J]. J Craniomaxillofac Surg, 2013, 41(7):648-651.
[13] Flaitz CM. Parotitis as the initial sign of juvenile Sjogren's syndrome [J]. Pediatr Dent, 2001, 23(2):140-142.
[14] Mignogna MD, Fedele S, Lo Russo L, et al. Sjogren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia [J]. J Oral Pathol Med, 2005, 34(1):1-6.
[15] Scully C, Georgakopoulou EA. Oral Involvement[M]// Ramos-Casals M, Stone J H, Moutsopoulos HM. Sjogren's Syndrome.London: Springer-Verlag, 2012: 86-102.
[16] Tzioufas AG, Tatouli IP, Moutsopoulos HM. Autoantibodies in Sjogren's syndrome: clinical presentation and regulatory mechanisms [J]. Presse Med, 2012, 41(9 Pt 2):e451-e460.
[17] Huo AP, Lin KC, Chou CT. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome[J]. Int J Rheum Dis, 2010, 13(1):39-47.
[18] Menéndez A, Gómez J, Escanlar E, et al. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection[J]. Autoimmunity, 2013, 46(1):32-39.
[19] Yoshimi R, Ueda A, Ozato K, et al. Clinical and pathological roles of Ro/SSA autoantibody system [J]. Clin Dev Immunol, 2012, 2012:606195.
[20] Yazisiz V, Avci AB, Erbasan F, et al. Diagnostic performance of minor salivary gland biopsy, serological and clinical data in Sjogren's syndrome: a retrospective analysis[J]. Rheumatol Int, 2009, 29(4):403-409.
[21] Brito-Zerón P, Pérez-Alvarez R, Pérez-de-Lis M. Laboratory abnormalities in primary Sjogren's syndrome[M]// Ramos-Casals M, Stone J H, Moutsopoulos HM. Sjogren's Syndrome. London: Springer-Verlag, 2012: 348-360.
[22] Friedman J, Klepfish A, Miller EB, et al. Agranulocytosis in Sjogren's syndrome: two case reports and analysis of 11 additional reported cases[J]. Semin Arthritis Rheum, 2002, 31(5):338-345.
[23] Ramos-Casals M, Font J, Garcia-Carrasco M, et al. Primary Sjogren syndrome: hematologic patterns of disease expression [J]. Medicine (Baltimore), 2002, 81(4):281-292. |